THUY KOLOMIYETS: Open Payments
NPI 1578156238 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 23 payments from 13 companies in 2025. Trend: 2023 $826 · 2024 $582 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $194 |
| ABBVIE INC. | 4 | $160 |
| Novo Nordisk Inc | 2 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| Esperion Therapeutics, Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Renalytix AI, Inc. | 1 | $23 |
| ABIOMED | 1 | $22 |
| Medtronic, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: FARXIGA, Ozempic, QULIPTA, AIRSUPRA, Kerendia, NEXLETOL, LINZESS, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
